Herpes Zoster: all 370 studies
Page 1 of 4. Open to participants first (63), then studies with results posted, then the rest; newest registration first within each.
- Immunogenicity and Safety of SYS6052 in the Participants Aged 40 Years and AboveNot yet recruitingNCT07892989Phase 1/2
- Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled TrialNot yet recruitingNCT07818356Phase 4
- A Study Exploring the Effect of Adjuvanted RZV or RSVPreF3 Vaccines on Coronary Plaque Progression in Adults >=50 Years of Age at Risk for Cardiovascular EventsNot yet recruitingNCT07712380Phase 2
- Reduced Vaccine Response to HZ/su in SLERecruitingNCT07636044
- Long-term Effectiveness of the Live Attenuated Herpes Zoster VaccineRecruitingNCT07585370
- A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in FinlandRecruitingNCT07502560Phase 4
- Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and AboveNot yet recruitingNCT07481604Phase 2
- Erector Spinae Plane Block Versus Transcutaneous Radiofrequency in Postherpetic NeuralgiaRecruitingNCT07400640
- Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA VaccineRecruitingNCT07400003Phase 1/2
- The Analgesic Efficacy and Safety of Loxoprofen Sodium Patch in Patients With Herpes ZosterRecruitingNCT07378059Not applicable
- The Analgesic Efficacy and Safety of Baclofen in Patients With Herpes ZosterRecruitingNCT07378046Not applicable
- The Analgesic Efficacy and Safety of Flurbiprofen Patch in Patients With Herpes ZosterRecruitingNCT07370402Not applicable
- The Analgesic Efficacy and Safety of Tulodesvenlafaxine in Patients With Herpes ZosterRecruitingNCT07370389Not applicable
- The Analgesic Efficacy and Safety of Desvenlafaxine in Patients With Herpes ZosterRecruitingNCT07361809Not applicable
- The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes ZosterRecruitingNCT07361796Not applicable
- Immunogenicity and Safety of SYS6017 in the Participants Aged 40 Years and AboveNot yet recruitingNCT07354659Phase 2
- The Analgesic Efficacy and Safety of Crisugabalin in Patients With Herpes ZosterRecruitingNCT07307976Not applicable
- The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes ZosterRecruitingNCT07307170Not applicable
- A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy ParticipantsNot yet recruitingNCT07205796Phase 2
- Transcutaneous Auricular Vagus Nerve Stimulation on Post-Herpetic NeuralgiaRecruitingNCT07123987Not applicable
- Efficacy and Safety of Brivudine in the Treatment of Herpes ZosterRecruitingNCT07099157Phase 4
- Clinical Study on the Treatment of Herpes Zoster Pain With Dexmedetomidine Combined With Long-term High VoltageRecruitingNCT06978192Phase 2
- Comparative Efficacy of Pregabalin and Lacosamide in Patients With Herpes Zoster and Post Herpetic NeuralgiaRecruitingNCT06969417Not applicable
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IV Clinical Trial to Evaluate the Immunogenicity and Safety of a Live Attenuated Herpes Zoster Vaccine in Adults Aged 40 Years and OlderNot yet recruitingNCT06961721Phase 4
- High-Voltage Long-Duration Pulsed Radiofrequency Combined With Liposomal Bupivacaine Subcutaneous Block for Herpes Zoster-Associated NeuralgiaRecruitingNCT06959147Phase 4
- Safety and Immunogenicity of SYS6017 in Healthy Participants Aged 40 Years or MoreNot yet recruitingNCT06954818Phase 1
- The Efficacy of High-frequency Short-time Spinal Cord Stimulation in the Treatment of Herpes Zoster-associated NeuralgiaRecruitingNCT06942806
- A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy IndividualsRecruitingNCT06932523Phase 1/2
- Esketamine Combined With PRF of DRG for Acute/Subacute Zoster-associated PainNot yet recruitingNCT06914206Not applicable
- A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.RecruitingNCT06903078
- Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP VaccineNot yet recruitingNCT06891872Phase 4
- Esketamine Combined Pulsed Radiofrequency for Acute/Subacute Zoster-associated Trigeminal NeuralgiaRecruitingNCT06890897Not applicable
- Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and OlderRecruitingNCT06874842Phase 1
- Neuropathic Pain and Traditional Medicine Syndromes in Herpes Zoster: a Cross-Sectional StudyNot yet recruitingNCT06870877
- To Investigate the Relationship Between the Viscoelastic Properties of the Zona Pellucida of Human Oocyte and the Blastocyst Utilization RateRecruitingNCT06839495
- A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Herpes Zoster VaccineNot yet recruitingNCT06801509Phase 1/2
- Multimodal Nerve Block and Pulse Radiofrequency for Acute Herpes Zoster PainNot yet recruitingNCT06798662Not applicable
- Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic DiseasesEnrolling by invitationNCT06763783Phase 4
- Impact on Quality of Life and Burden of Disease in Adults With Herpes ZosterNot yet recruitingNCT06667245
- Electroacupuncture Regulation of Immune Cells in Herpes ZosterRecruitingNCT06643247Not applicable
- An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella VaccineEnrolling by invitationNCT06484686Phase 4
- Correlation of Protection Against Varicella in an Exploratory StudyNot yet recruitingNCT06482216
- Ultrasound Guided Serratus Anterior Versus Erector Spinae Block in Pain Alleviation in Acute Herpes ZosterNot yet recruitingNCT06476080Not applicable
- Risk Factors of Anxiety and Depression in Patients With Herpes Zoster NeuralgiaRecruitingNCT06449547
- Predictive Models for the Treatment of Recurrent Herpes Zoster Neuralgia Following Spinal Cord Electrical Stimulation.Enrolling by invitationNCT06410222
- Biological and Clinical Efficacy of Shingrix in Patients With CLLNot yet recruitingNCT06364033Not applicable
- Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and AboveRecruitingNCT06137755Phase 1
- A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster VaccineRecruitingNCT06088745Phase 3
- Immunogenicity, Reactogenicity of Shingrix in SLERecruitingNCT06001606Phase 3
- Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated VaccinesNot yet recruitingNCT05952505Phase 4
- Herpes Zoster Hospitalizations in ItalyRecruitingNCT05952271
- Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis PatientsRecruitingNCT05596526Phase 4
- Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control PopulationRecruitingNCT05580458Phase 1/2
- Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant RecipientsRecruitingNCT05554068Phase 2
- Epidural Platelet Rich Plasma Injection for Herpes ZosterRecruitingNCT05538364
- Effect of Peripheral Vestibular Disease Location on Outcomes Following Home-based Virtual Reality Vestibular TherapyRecruitingNCT05424302Not applicable
- Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella VaccinationRecruitingNCT05422508Phase 2
- Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric PatientsRecruitingNCT05198570
- An Immunity Persistence Study of Live Attenuated Varicella VaccineEnrolling by invitationNCT05095701Phase 4
- Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years OldEnrolling by invitationNCT05015686Phase 3
- Shingrix in Renal Transplant RecipientsRecruitingNCT04128189Phase 3
- A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney TransplantRecruitingNCT04006808Phase 1/2
- Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation RecipientsRecruitingNCT00492739Phase 2/3
- Nudging Patients to Increase Shingles VaccinationCompletedNCT06238726Not applicableResults posted
- A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy AdultsCompletedNCT05966090Phase 3Results posted
- A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in IndiaCompletedNCT05219253Phase 3Results posted
- A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster VaccineCompletedNCT05047770Phase 3Results posted
- Efficacy, Immunogenicity and Safety Study of GSKs Recombinant Zoster Vaccine Shingrix (GSK1437173A) in Chinese Adults Aged ≥50 YearsCompletedNCT04869982Phase 4Results posted
- A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune ResponseCompletedNCT04176939Phase 3Results posted
- Persistence of Protection by ShingrixCompletedNCT04169009Phase 4Results posted
- Safety and Immunogenicity Study of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) With a Prior Episode of Herpes ZosterCompletedNCT04091451Phase 3Results posted
- Systems Biology of Zoster VaccineCompletedNCT04047979Phase 2Results posted
- Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With VedolizumabCompletedNCT03798691Phase 4Results posted
- Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)CompletedNCT03702231Phase 2Results posted
- A Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022CompletedNCT03563183Results posted
- Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and OlderCompletedNCT03439657Phase 3Results posted
- Zoster Eye Disease StudyCompletedNCT03134196Phase 4Results posted
- Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of AgeCompletedNCT02979639Phase 3Results posted
- Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™CompletedNCT02958345Phase 4Results posted
- Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and OlderCompletedNCT02735915Phase 3Results posted
- A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older AdultsCompletedNCT02723773Phase 3Results posted
- Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.CompletedNCT02690207Phase 3Results posted
- Immune Response to Shingles VaccinationCompletedNCT02624375Phase 4Results posted
- Enhancing a Sustainable Pharmacy-based Immunization Program in Two StatesCompletedNCT02615470Not applicableResults posted
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years EarlierCompletedNCT02581410Phase 3Results posted
- A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.CompletedNCT02570126Phase 3Results posted
- Study to Evaluate Immunogenicity, Safety, and Tolerability of ZOSTAVAX™ Vaccine (Zoster Vaccine Live, V211) Administered Concomitantly Versus Nonconcomitantly With Quadrivalent Influenza Virus Vaccine (Inactivated) in Participants ≥50 Years of Age (V211-062)CompletedNCT02519855Phase 3Results posted
- Burden of Herpes Zoster and Post-herpetic Neuralgia Among People ≥ 50 Years Old in FranceCompletedNCT02487472Results posted
- ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ TumorsTerminatedNCT02444936Phase 4Results posted
- Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster KeratitisTerminatedNCT02382588Phase 2Results posted
- Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of AgeCompletedNCT02075515Phase 3Results posted
- Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal TransplantCompletedNCT02058589Phase 3Results posted
- Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and OlderCompletedNCT02052596Phase 3Results posted
- Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and OlderCompletedNCT02045836Phase 3Results posted
- Phase III Study of ASP2151 in Herpes Zoster PatientsCompletedNCT01959841Phase 3Results posted
- Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and OlderCompletedNCT01954251Phase 3Results posted
- T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020CompletedNCT01911065Phase 4Results posted
- Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes ZosterCompletedNCT01827839Phase 3Results posted
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving ChemotherapyCompletedNCT01798056Phase 3Results posted
- Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 YearsCompletedNCT01777321Phase 3Results posted